Bio Protocol vs Neo — how do they compare? Bio Protocol trades at Rp512.14 (market cap Rp1,15T, Rp263,61M 24h volume), while Neo trades at Rp34,710 (market cap Rp2,44T, Rp83M 24h volume). The key difference: Neo is far larger — about 2.1× Bio Protocol's market cap, and Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while Neo's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and Neo for 93 Days on average.
| BIO | NEO | |
|---|---|---|
Market Cap | Rp1,15T | Rp2,44T |
Volume (24h) | Rp263,61M | Rp83M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 70,5M NEO |
Typical Hold Time | 16 Days | 93 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
Neo is currently trading at Rp34,766 with a market cap of Rp2.45T, showing bearish technical signals as moving averages indicate selling pressure while oscillators remain neutral. The token faces immediate support at Rp33,757 with resistance at Rp35,227. Recent network activity shows moderate developer engagement but limited major protocol upgrades in the current cycle.
Overall outlook remains cautious with technical weakness outweighing neutral momentum indicators. Key opportunities include potential bounce from support levels, while risks involve continued bearish momentum and limited ecosystem growth. Investors should monitor network adoption metrics and trading volume patterns for directional cues.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Neo is a smart contract platform, similar to Ethereum, that was created in China. It labels itself as a “rapidly growing and developing” ecosystem with the goal to become the foundation for the next generation of the internet — a new economy where digitized payments, identities, and assets come together.
Read more on NEO →